Mario Alejandro Aguilar-Chaparro
Overview
Explore the profile of Mario Alejandro Aguilar-Chaparro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
2
Citations
1
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aguilar-Chaparro M, Rivera-Pineda S, Hernandez-Galdamez H, Rios-Castro E, Garibay-Cerdenares O, Pina-Vazquez C, et al.
J Cell Biochem
. 2025 Feb;
126(2):e70003.
PMID: 39943801
Hepatocellular carcinoma (HCC) is a formidable malignancy, with growing interest in identifying cancer stem cells (CSCs) as potential therapeutic targets. CD44 isoforms have emerged as promising CSC markers in HCC,...
2.
Hernandez-Galdamez H, Fattel-Fazenda S, Flores-Tellez T, Aguilar-Chaparro M, Mendoza-Garcia J, Diaz-Fernandez L, et al.
Food Funct
. 2024 Apr;
15(8):4586-4602.
PMID: 38590223
Hepatocellular carcinoma (HCC) is a tumor with minimal chance of cure due to underlying liver diseases, late diagnosis, and inefficient treatments. Thus, HCC treatment warrants the development of additional strategies....
3.
Aguilar-Chaparro M, Rivera-Pineda S, Hernandez-Galdamez H, Pina-Vazquez C, Villa-Trevino S
Stem Cell Res
. 2023 Oct;
72:103222.
PMID: 37844417
Hepatocellular carcinoma (HCC) is a type of liver cancer, in which CD44 isoforms have been proposed as markers to identify cancer stem cells (CSCs). However, it is unclear what characteristics...